These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Usefulness of FEES and responsiveness to tetrabenazine in a case of blepharospasm associated with dystonic-tremorous dsyphagia. Suttrup I; Suntrup S; Oelenberg S; Hamacher C; Dziewas R; Warnecke T Parkinsonism Relat Disord; 2014 Apr; 20(4):466-7. PubMed ID: 24495710 [No Abstract] [Full Text] [Related]
43. The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis. Naderi F; Javadi SA; Motamedi M; Sahraian MA Clin Neuropharmacol; 2012; 35(5):224-6. PubMed ID: 22821064 [TBL] [Abstract][Full Text] [Related]
44. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Jankovic J Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467 [TBL] [Abstract][Full Text] [Related]
45. The suppression of involuntary movements with tetrabenazine. McLellan DL Scott Med J; 1972 Nov; 17(11):367-70. PubMed ID: 4264428 [No Abstract] [Full Text] [Related]
46. Successful use of tetrabenazine in a patient with intractable hiccups after stroke. Naro A; Bramanti P; CalabrĂ² RS Pharmacotherapy; 2014 Dec; 34(12):e345-8. PubMed ID: 25471210 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies. Mehvar R; Jamali F; Watson MW; Skelton D Drug Metab Dispos; 1987; 15(2):250-5. PubMed ID: 2882986 [TBL] [Abstract][Full Text] [Related]
49. Lithium-induced tremor treated with vitamin B6: a preliminary case series. Miodownik C; Witztum E; Lerner V Int J Psychiatry Med; 2002; 32(1):103-8. PubMed ID: 12075913 [TBL] [Abstract][Full Text] [Related]
50. Asymmetric postural tremor preceding DOPA-responsive Parkinsonism - the transition disease. Wolters A; Walter U; Wittstock M; Benecke R J Parkinsons Dis; 2014; 4(1):45-55. PubMed ID: 24398659 [TBL] [Abstract][Full Text] [Related]
51. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease. Sung YH; Chung SJ; Kim SR; Lee MC Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649 [TBL] [Abstract][Full Text] [Related]
52. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor. Tarsy D; Scollins L; Corapi K; O'Herron S; Apetauerova D; Norregaard T Stereotact Funct Neurosurg; 2005; 83(5-6):222-7. PubMed ID: 16534254 [TBL] [Abstract][Full Text] [Related]
53. How best to address these common movement disorders. Yaman A; Akdeniz M; Yaman H J Fam Pract; 2011 Dec; 60(12):721-5. PubMed ID: 22163354 [No Abstract] [Full Text] [Related]
54. [Abnormal involuntary movements in the elderly and their treatment (author's transl)]. Delwaide PJ; Desseilles M Sem Hop; 1978 Nov 18-25; 54(41-42):1247-9. PubMed ID: 32624 [TBL] [Abstract][Full Text] [Related]
55. Is history of depression a contraindication to treatment with tetrabenazine? Kenney C; Hunter C; Mejia N; Jankovic J Clin Neuropharmacol; 2006; 29(5):259-64. PubMed ID: 16960470 [TBL] [Abstract][Full Text] [Related]
56. Treatment of Traumatic Brain Injury-Induced Dyskinesia With Tetrabenazine: A Case Report. Lauterbach MD; Notarangelo PL; Lane KS; Koliatsos VE Psychosomatics; 2015; 56(5):567-71. PubMed ID: 25591493 [No Abstract] [Full Text] [Related]
57. Neurotransmitter depleter tetrabenazine; potential candidate for schizophrenia treatment? Malik A; Balkoski V Schizophr Res; 2007 Nov; 96(1-3):267-8. PubMed ID: 17683910 [No Abstract] [Full Text] [Related]
58. Tetrabenazine in the treatment of severe pediatric chorea. Chatterjee A; Frucht SJ Mov Disord; 2003 Jun; 18(6):703-6. PubMed ID: 12784277 [TBL] [Abstract][Full Text] [Related]
59. Repetitive administration of tetrabenazine induces irreversible changes in locomotion and morphology of the substantia nigra in rats. Satou T; Anderson AJ; Itoh T; Tamai Y; Hayashi Y; Hashimoto S Exp Toxicol Pathol; 2001 Sep; 53(4):303-8. PubMed ID: 11665855 [TBL] [Abstract][Full Text] [Related]